SCHEMBL8323292

SCHEMBL8323292

COc1cc2nc(C3CC3)c(/C=C/C(O)CC(O)CC(=O)O)c(-c3ccc(Cl)cc3)c2cc1OC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 3/20 0.62
NR4A2 P43354 2/20 0.62
NR1I2 O75469 2/20 0.62
HMGCR P04035 5/20 0.54
RXRA P19793 3/20 0.54
TBXA2R P21731 2/20 0.43
ADRA1A P35348 2/20 0.43
ESR1 P03372 1/20 0.43
CHRM1 P11229 1/20 0.43
PDE4A P27815 1/20 0.43
LMNA P02545 1/20 0.38
FABP4 P15090 1/20 0.38
FABP5 Q01469 1/20 0.38
CYP2C9 P11712 3/20 0.36
SIRT6 Q8N6T7 2/20 0.36
ABCC3 O15438 1/20 0.36
ABCB11 O95342 1/20 0.36
PGR P06401 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CCKAR P32238 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8323630 0.93 NR4A2 (0.68) PDE4DNR4A2NR1I2HMGCRRXRA
SCHEMBL8320769 0.92 PDE4D (0.75) PDE4DNR4A2NR1I2HMGCRRXRA
SCHEMBL8321515 0.89 PDE4D (0.69) PDE4DNR4A2NR1I2HMGCRRXRA
SCHEMBL8323698 0.88 PDE4D (0.65) PDE4DNR4A2NR1I2HMGCRRXRA
SCHEMBL8327007 0.86 HMGCR (0.56) PDE4DNR4A2NR1I2HMGCRRXRA
SCHEMBL8318443 0.86 NR4A2 (0.83) PDE4DNR4A2NR1I2HMGCRRXRA
SCHEMBL8318209 0.85 NR4A2 (0.71) PDE4DNR4A2NR1I2HMGCRRXRA
SCHEMBL8321759 0.84 PDE4D (0.78) PDE4DNR4A2NR1I2HMGCRRXRA
SCHEMBL8319301 0.82 PDE4D (0.75) PDE4DNR4A2NR1I2HMGCRRXRA
SCHEMBL8323363 0.80 NR4A2 (0.71) PDE4DNR4A2NR1I2HMGCRRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0304063-B1 Quinoline type mevalonolactones NISSAN CHEMICAL IND LTD (JP) 1994-11-30 EP claimed
EP-0304063-A2 Quinoline type mevalonolactones NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1989-02-22 EP claimed
US-5872130-A ANTI-HYPERLIPIDEMIC, HYPOLIPOPROTEINEMIC AND ANTI-ATHEROSCLEROTIC AGENTS NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1999-02-16 US disclosed
US-5856336-A Quinoline type mevalonolactones NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1999-01-05 US disclosed
US-5854259-A Quinoline type mevalonolactones NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1998-12-29 US disclosed
EP-0304063-B1 Quinoline type mevalonolactones NISSAN CHEMICAL IND LTD (JP) 1994-11-30 EP disclosed
US-5185328-A Hydroxy-3-methylglutaryl/3-/ coenzyme A reductase inhibitors NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1993-02-09 US disclosed
US-5102888-A QUINOLINE TYPE MEVALONOLACTONES USEFUL FOR TREATING HYPERLIPIDEMIA AND RELATED DISEASES NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1992-04-07 US disclosed
US-5011930-A Antilipemic agents, anticoagulants NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1991-04-30 US disclosed
EP-0304063-A2 Quinoline type mevalonolactones NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1989-02-22 EP disclosed